NasdaqGM - Delayed Quote USD

ArriVent BioPharma, Inc. (AVBP)

24.50
+0.90
+(3.81%)
At close: June 10 at 4:00:01 PM EDT
All numbers in thousands
Download
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
274,942
163,098
182,833
43,039
Total Liabilities Net Minority Interest
17,288
316,291
267,942
1,818
Total Equity Gross Minority Interest
257,654
-153,193
-85,109
41,221
Total Capitalization
257,654
-153,193
-85,109
41,221
Preferred Stock Equity
--
--
--
89,865
Common Stock Equity
257,654
-153,193
-85,109
-48,644
Capital Lease Obligations
176
317
139
0
Net Tangible Assets
257,654
-153,193
-85,109
41,221
Working Capital
209,705
148,344
174,262
41,134
Invested Capital
257,654
-153,193
-85,109
-48,644
Tangible Book Value
257,654
-153,193
-85,109
-48,644
Total Debt
176
317
139
0
Share Issued
33,706.77
31,956.66
31,956.66
31,956.66
Ordinary Shares Number
33,706.77
31,956.66
31,956.66
31,956.66
12/31/2021 - 1/26/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MBX MBX Biosciences, Inc.
11.46
+0.84%
 
CTNM Contineum Therapeutics, Inc.
4.8800
+8.93%
 
CGEM Cullinan Therapeutics, Inc.
9.03
+3.08%
 
ALMS Alumis Inc.
3.3600
-2.04%
 
IPHA Innate Pharma S.A.
1.9800
-4.81%
 
RAPP Rapport Therapeutics, Inc.
13.16
+3.54%
 
9969.HK InnoCare Pharma Limited
12.960
-2.41%
 
BCAX Bicara Therapeutics Inc.
12.58
+9.58%
 
UPB Upstream Bio, Inc.
11.59
+2.66%
 
XNCR Xencor, Inc.
9.74
+1.99%